PIM
SKYE icon

Platinum Investment Management’s Skye Bioscience SKYE Stock Holding History

Platinum Investment Management’s Portfolio SKYE Stock Details SKYE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$143K Hold
233,095
– – 0.04% 89
2025
Q4 		$175K Hold
233,095
– – 0.04% 95
2025
Q3 		$916K Sell
233,095
-60,225
-21% -$227K 0.06% 85
2025
Q2 		$1.23M Hold
293,320
– – 0.08% 71
2025
Q1 		$466K Sell
293,320
-140,726
-32% -$384K 0.03% 80
2024
Q4 		$1.23M Sell
434,046
-51,153
-11% -$214K 0.07% 74
2024
Q3 		$1.9M Buy
+485,199
New +$2.72M 0.09% 68

Other funds holding SKYE

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Platinum Investment Management's SKYE Position: Q1 2026 in Review

Platinum Investment Management held its Skye Bioscience (SKYE) position steady in Q1 2026 at 233,095 shares worth $143K. The position accounts for 0.04% of the portfolio, ranked #89.

Platinum Investment Management first reported a position in SKYE in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.9M in Q3 2024. 39 funds tracked by Wall St. Rank hold SKYE as of Q1 2026.

  • Platinum Investment Management held 233,095 shares of Skye Bioscience worth $143K as of Q1 2026.
  • Platinum Investment Management left its Skye Bioscience share count unchanged in Q1 2026.
  • Skye Bioscience made up 0.04% of Platinum Investment Management's portfolio in Q1 2026, its #89 holding.
  • Platinum Investment Management first reported a position in Skye Bioscience in Q3 2024 and has held it in 7 quarters since.
  • Platinum Investment Management's Skye Bioscience position peaked at $1.9M in Q3 2024.
  • 39 funds tracked by Wall St. Rank held Skye Bioscience as of Q1 2026.

Based on Platinum Investment Management's 13F filing for Q1 2026, filed 14 May 2026.